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Article focus
  Many metal-on-metal hip arthroplasty 
designs have failed earlier than expected 
due to adverse reactions to metal debris 
(ARMD), whilst metal-on-polyethylene 
hip arthroplasties traditionally fail later 
from aseptic loosening.
  t-cells are considered to play an impor-
tant role in the cellular reaction related 
to arthroplasty failure. this study investi-
gated the composition and distribution of 
CD4+ t-cell phenotypes in the peripheral 
blood and synovial fluid of patients under-
going revision surgery for failed metal-
on-metal and metal-on-polyethylene hip 
arthroplasties, and in a control group of 
patients awaiting total hip arthroplasty.
  the phenotypes recognised were naïve 
or memory cells, the latter being of 
different effector types with distinctive 
activities in inflammatory immune 
processes.
Increased expression of inducible 
co-stimulator on cD4+ T-cells in the 
peripheral blood and synovial fluid of 
patients with failed hip arthroplasties
Objectives
T-cells are considered to play an important role in the inflammatory response causing arthro-
plasty failure. The study objectives were to investigate the composition and distribution 
of cD4+ T-cell phenotypes in the peripheral blood (pB) and synovial fluid (sF) of patients 
undergoing revision surgery for failed metal-on-metal (MoM) and metal-on-polyethylene 
(Mop) hip arthroplasties, and in patients awaiting total hip arthroplasty.
Methods
In this prospective case-control study, pB and sF were obtained from 22 patients (23 hips) 
undergoing revision of MoM (n = 14) and Mop (n = 9) hip arthroplasties, with eight controls 
provided from primary hip osteoarthritis cases awaiting arthroplasty. Lymphocyte subtypes 
in samples were analysed using flow cytometry.
Results
The percentages of cD4+ T-cell subtypes in pB were not different between groups. The cD4+ 
T-cells in the sF of MoM hips showed a completely different distribution of phenotypes com-
pared with that found in the pB in the same patients, including significantly decreased cD4+ 
T-central memory cells (p < 0.05) and increased T-effector memory cells (p < 0.0001) in 
the sF. Inducible co-stimulator (Icos) was the only co-stimulatory molecule with different 
expression on cD4+ cD28+ cells between groups. In pB, Icos expression was increased in 
MoM (p < 0.001) and Mop (p < 0.05) cases compared with the controls. In sF, Icos expres-
sion increased in MoM hips compared with Mop hips (p < 0.05).
Conclusions
Increased expression of Icos on cD4+ T-cells in pB and sF of patients with failed arthroplas-
ties suggests that these cells are activated and involved in generating immune responses. 
Variations in Icos expression between MoM and Mop hips may indicate different modes of 
arthroplasty failure.
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Key messages
  Increased expression of Inducible Co-stimulator on 
CD4+CD28+ t-cells in the peripheral blood and syno-
vial fluid of patients with failed arthroplasties com-
pared with controls suggests these cells are activated 
and may generate immune responses to implants.
  Increased expression of Inducible Co-stimulator by 
lymphocytes in the synovial fluid of metal-on-metal 
hips compared to metal-on-polyethylene hips may 
explain the different modes of failure observed 
(adverse reaction to metal debris versus aseptic loos-
ening) with these two different bearing surfaces.
  this study suggests that peripheral blood examina-
tion using these t-cell markers has limited potential 
to detect immune responses occurring in relation to 
artificial joint arthroplasty failure.
Strengths and limitations
  Strengths – this is the first study to perform simulta-
neous analysis of lymphocyte subtypes in both the 
peripheral blood and synovial fluid of patients with 
different types of failed hip arthroplasties.
  limitations – (1) It was not possible to obtain suffi-
cient quantities of synovial fluid for analysis in all 
revised hips. (2) Inevitably, the number of patients 
available for a detailed prospective single centre study 
of this type is small, and the ability to perform such 
specialised experimental procedures in a standard-
ised way across laboratories so as to combine results 
meaningfully in a multi-centre study is limited.
introduction
the cellular reaction to wear particles in the periprosthetic 
tissues of artificial joint arthroplasties has long been con-
sidered a significant contributor to implant loosening in 
the absence of infection.1 Accumulating evidence demon-
strates that in aseptic loosening of arthroplasties there are 
lymphocytes present in the interface fibrous tissue 
admixed with macrophages and foreign body multinucle-
ate giant cells (MNGC).2-5 While controversy exists as to 
whether these lymphocytes are instrumental in implant 
failure, either in aseptic loosening or adverse reaction to 
metal debris (ARMD),6,7 several lines of evidence suggest 
that t-cell mediated type Iv hypersensitivity to metals may 
play a role in some cases of aseptic loosening. Blood ves-
sels at the interface show increased expression of P-selectin 
and E-selectin, cell adhesion molecules associated with 
migration of lymphocytes in immune-mediated inflam-
mation.8 the t-cells at the interface tissue are activated 
and proliferating as evidenced by the expression of human 
leukocyte antigen (hlA) class II, proliferation nuclear anti-
gen, and presence of the cytokines interleukin-2 (Il-2) and 
-15 (Il-15).9,10 Finally, lymphocytes and macrophages 
interact with active antigen presentation occurring in the 
periprosthetic tissue, as demonstrated by increased 
expression of the co-stimulatory molecules CD80, CD86, 
CD40, and intracellular adhesion molecule-1 (ICAM-1) on 
macrophages, with the counter-ligands CD28, CD40l, 
and lymphocyte function-associated antigen-1 (lFA-1) 
present on t-cells.11-13
Studies examining peripheral blood from hip 
arthroplasty patients have demonstrated evidence of 
antigen-presenting cells (APCs) in those individuals with 
metal-on-metal (MoM) bearing surfaces, but not in those 
with metal-on-polyethylene (MoP) bearings or in former 
MoM patients after revision to MoP articulations.14 the 
question arises as to whether more detailed analysis of 
t-cell subtypes might provide further information with 
respect to the differentiation of pathogenetic mecha-
nisms as well as aiding in diagnosis. Following antigen 
exposure, CD4+ and CD8+ t-cells can differentiate from 
naïve cells (tN) through central memory (tCM), then 
effector memory (tEM), and finally to terminally differen-
tiated effector memory (tEMRA) states.15,16
these phenotypes of t-cells can be distinguished on 
the basis of their expression of the lymphoid homing 
chemokine receptor CCR7 and the phosphatase CD45RA 
as follows: tN cells (CCR7+CD45RA+), tCM cells 
(CCR7+CD45RA−), tEM cells (CCR7−CD45RA−) and tEMRA 
cells (CCR7-CD45RA+).15,16 Central memory t-cells have 
the ability to home to secondary lymphoid organs but 
have little or no effector function.15,16 By contrast, tEM 
and tEMRA cells display immediate effector function by 
rapid entry into a site of inflammation and secretion of 
large amounts of cytokines.15,16 Although some studies 
have analysed lymphocyte subtypes in the peripheral 
blood (PB) of patients with different types of hip arthro-
plasty, none performed simultaneous analysis of the syn-
ovial fluid (SF).14,17-21
the study aims were to investigate the composition 
and distribution of CD4+ t-cell phenotypes in the PB and 
SF of patients undergoing revision surgery for failed MoM 
and MoP hip arthroplasties, and in patients with primary 
osteoarthritis awaiting total hip arthroplasty (thA).
Materials and Methods
Study design and inclusion criteria. this prospective case-
control study was undertaken at one specialist arthro-
plasty centre. Ethical approval for this study was granted 
(REC Reference 09/h1010/75) with all subjects providing 
written informed consent.
Patients scheduled for revision of MoM or MoP hip 
arthroplasties (cases) and patients with primary hip oste-
oarthritis awaiting thA (controls) were recruited for this 
study over a one-year period (August 2011 to August 
2012). the study exclusion criteria barred patients with 
suspected or confirmed deep prosthetic infection, those 
with known inflammatory arthritis, and any individual on 
immunosuppressive medications. there were 31 hips in 
30 patients eligible for study inclusion (table I). All cases 
had initially undergone their index hip arthroplasty for 
primary osteoarthritis. A total of six surgeons performed 
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all the revision operations. A diagnosis of ARMD was con-
firmed only after histopathological examination and was 
graded as previously recommended.7
Whole blood was collected from patients with failed 
MoM (n = 14) and MoP (n = 9) hip arthroplasties immedi-
ately prior to revision surgery and in patients from the con-
trol group prior to primary thA (n = 8). It was not always 
possible for the revision surgeon to obtain sufficient quan-
tities of SF for analysis to enable the extraction of mononu-
clear cells, although it was attempted in all cases. Suitable 
SF samples were available from 11 MoM and six MoP revi-
sions. All PB and SF samples were immediately taken to the 
laboratory and processed within 24 hours of collection.
Sample validation and processing. Sample processing to 
isolate peripheral blood mononuclear cells (PBMCs) and 
synovial fluid mononuclear cells (SFMCs) was performed 
according to the standard protocols. to validate sample 
processing and flow cytometry, unstained PBMCs and 
SFMCs, as well as PBMCs and SFMCs spiked with BD fluo-
rescence-activated cell sorting (FACS) seven-colour setup 
beads, were used. PBMC in Ethylenediaminetetraacetic 
acid (EDtA) and SFMC were isolated by density gradi-
ent centrifugation on Ficoll-Paque PlUS (GE healthcare, 
Amersham, United Kingdom), washed twice with 
Dulbecco's Modified Eagle's Medium (DMEM) (Sigma-
Aldrich, Dorset, United Kingdom), counted using a 
Neubauer haemocytometer and re-suspended at 1 × 106 
cells/ml in fresh medium.
Flow cytometry. Mononuclear cells were stained for 
surface antigens using multiple fluorescent labelled 
monoclonal antibodies: CD3-PerCP Cy5.5 (eBiosci-
ence, hatfield, United Kingdom), CD4-Pacific blue 
(BD Biosciences, oxford, United Kingdom), CCR7-FItC 
(R&D Systems, Minneapolis, Minnesota), CD45RA-
APC (Biolegend, San Diego, California), ICoS-PE (BD 
Biosciences, oxford, United Kingdom), CD28-APC (BD 
Biosciences, oxford, United kingdom), CD14-Pacific 
Blue (Biolegend), CD86-FItC (BD Biosciences) at the 
dilutions recommended by the respective suppliers.
Analysis for tregulator cells (CD25 high CD127 dim FoXP3+) 
was carried out by first surface staining the cells with 
CD3-FItC (BD Bioscience), CD4-Pacific blue (eBiosci-
ence), CD25-APC (BD Bioscience) and CD127-Pe-Cy7 
(eBioscience), followed by fixation and permeabilisation 
using the FoXP3 Staining Buffer Set (Fix/Perm concen-
trate and diluent) (eBioscience), according to manufac-
turer’s instructions. Expression of FoXP3 was detected 
using FoXP3-PE antibody (eBioscience).
For cytokine expression, mononuclear cells were stim-
ulated with 0.05 µg/ml phorbol myristate acetate (PMA) 
(Sigma-Aldrich) and 1µM ionomycin (Sigma-Aldrich) for 
four hours at 37°C in the presence of 10 µg/ml of brefel-
din A (Sigma-Aldrich). Immunophenotyping of samples 
was performed with CD3-FItC (BD Biosciences) and CD4-
Pacific blue (eBioscience). After this staining for surface 
antigens, intracellular staining was performed using fixa-
tion and permeabilisation kit (Invitrogen, loughborough, 
United Kingdom) according to manufacturer's instruc-
tions. Intracellular cytokines were detected using different 
colour fluorescent conjugated antibodies: Il-17A-PE (eBi-
oscience), Il-4-Pe-Cy7 (BD Bioscience, oxford, United 
Kingdom), and interferon (IFN)-γ-APC (BD Biosciences). 
All stained cells were run on a CyAn ADP Analyzer 
(Beckman Coulter Inc., Fullerton, California), and the data 
analysed using Summit v4.3 software (Beckman Coulter 
Inc.).
Statistical analysis. All statistical analysis was performed 
using GraphPad Prism 3.0 (GraphPad Software Inc., la 
Jolla, California). Depending on data distribution, either 
the mean and range or median and interquartile range 
have been provided. Analysis of paired samples (PB and 
SF from the same patient) was performed using the 
Wilcoxon signed-rank test. Analysis of independent sam-
ples (all comparisons between case and control samples) 
was performed using the Mann-Whitney U test. the level 
of statistical significance was set at p < 0.05.
Results
Revision indication. the indication for revision in 13 of 
14 MoM hips was ARMD, with all patients with ARMD 
having raised whole blood metal ion levels and/or cross-
sectional imaging confirming the diagnosis. the specific 
Table i. Summary of clinical details of cohort (n = 31).
MoM hip revisions Mop hip revisions Control group
hips (patients) 14 (13) 9 (9) 8 (8)
Male (%):female (%) hips 6 (43):8 (57) 3 (33):6 (67) 1 (13):7 (87)
Mean age (range) at sampling (yrs) 59.8 (48.3 to 69.4) 72.7 (38.8 to 85.3) 60.4 (40.1 to 76.2)
Mean body mass index (range) (kg/m2) 29.3 (23.8 to 41.3) 26.5 (19.0 to 36.0) 24.7 (19.7 to 28.2)
Mean time implant in situ (range) (yrs) 6.4 (1.8 to 13.7) 18.9 (5.6 to 27.1) N/A
Indication for revision surgery (%) ARMD = 13 (93) Aseptic loosening = 1 (7) Aseptic loosening = 9 (100) N/A
Median (interquartile range) blood metal ion 
concentration in µg/l
Co = 10.0 (4.2 to 39.6) /Cr = 7.0 (3.0 to 42.0) N/A/N/A N/A/N/A
Implant revised (%) thA = 10 (71) /hR = 4 (29) thA = 9 (100) N/A
thA revision bearing used (%) oxP = 7 (50) /MoP = 3 (21) /CoC = 2 (14)/ 
CoP = 2 (14)
MoP = 8 (89) /CoP = 1 (11) N/A
ARMD = adverse reaction to metal debris; CoC, ceramic-on-ceramic; CoP, ceramic-on-polyethylene; Cr, chromium; Co, cobalt; hR, hip resurfacing; MoP, 
metal-on-polyethylene; N/A, not applicable; oxP, oxinium-on-polyethylene; thA, total hip arthroplasty
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histopathological findings in the ARMD cases were: ter-
tiary lymphoid organs with t-cells and B-cells (four hips), 
t-cell lymphocytic aggregates (four hips), diffuse lym-
phocytic infiltration with no aggregates (one hip), and 
macrophage response with variable amounts of intracel-
lular metal wear debris but no lymphocytic component 
(four hips). All nine MoP revisions were performed for 
aseptic loosening, which was confirmed after histopatho-
logical and microbiological analysis.
Analysis of memory phenotypes of CD4+ T-cells. the 
memory phenotypes of CD4+ t-cells were differentiated 
by investigating the expression of lymphoid homing che-
mokine receptor CCR7 and the phosphatase CD45RA 
(Fig. 1a). there were no significant differences in the 
percentages of CD4+ t-cell subtypes in PBMCs between 
the three study groups (Fig. 1b: controls, Fig. 1c: MoP, 
Fig. 1d: MoM).
the CD4+ t-cells in the SF of the MoM hips showed 
a completely different distribution of phenotypes 
compared with PBMCs in the same patients (Fig. 1d). 
there was a significant decrease in the CD4+ tN cells 
(p  <  0.0001) and CD4+ tCM cells (p < 0.05), together 
with a significant increase in tEM cell (p < 0.0001) popu-
lations in the SFMCs compared with the PBMCs of the 
MoM cases (Fig. 1d). too few SF samples were available 
from MoP revision cases to perform a similar paired 
analysis to compare t-cell memory phenotypes in the 
PB and SF, and analysis of SF from controls was not part 
of the study protocol.
Expression of co-stimulatory molecules. to assess t-cell 
activation and antigen presentation, we examined the 
expression of co-stimulatory molecules, CD86, CD80, 
CD40 and inducible co-stimulator ligand (ICoSl) on 
CD14+ monocytes and CD28, ICoS, CD40l on CD4+ 
t-cells (Fig. 2a). the percentage of CD4+CD28+ cells 
expressing ICoS did not differ in the PB between the revi-
sion and control groups (Fig. 2b). A significant increase in 
the expression of ICoS in PB, measured by median fluo-
rescent intensity, was detected in the MoM (p < 0.001) 
and MoP (p < 0.05) revision groups compared with the 
control group (Fig. 2c). the percentage of CD4+CD28+ 
t-cells was higher in the SF of MoM revisions compared 
with that of MoP revisions, though this was not statisti-
cally significant (Fig. 2d). however, a significant increase 
in the ICoS expression of CD4+CD28+ cells in the SF of 
the MoM revision group was observed compared with 
the MoP group (p < 0.05) (Fig. 2e). there were no other 
significant differences in any of the other co-stimulatory 
molecules between the groups. FACS analysis of PBMCs 
revealed no significant difference between the groups 
in the expression of CD28 and CD86 on the surface of 
CD4+ t-cells and CD14+ monocytes, respectively. No 
significant difference in CD28 expression was detected in 
the SFMCs between MoM and MoP revisions. little or no 
expression of CD80, CD40 and ICoS-l on PB monocytes 
or CD40l on PB CD4+ t-cells was detected.
Analysis of CD4+ T-cell subpopulations and cytokine 
expression. to further understand the immune response 
to MoM and MoP hips, the percentages of individual 
CD4+ t-helper (th) subsets, namely th1, th2, th17 and 
tregulator, were analysed in the PB. Cells are cultured in the 
presence of PMA and ionomycin. th1 cells are marked 
by their production of IFN-γ, th2 by Il4 production and 
th17 cells by the presence of Il-17A/F and Il-22, while 
tregulator cells specifically express the transcription factor 
FoXP3. No significant differences were observed in the 
profile of these CD4+ t-helper subtypes with respect to 
the expression of any of these markers by the PBMCs of 
the two revision groups compared with the control group 
on stimulation in culture with PMA and ionomycin. there 
were higher percentages of th1 IFNγ-producing cells 
than the other types in all three groups. Due to insuf-
ficient sample volumes it was not possible to perform a 
similar analysis of SF-derived cells between patients with 
MoM and MoP hips.
Discussion
this study aimed to characterise in detail the systemic 
and local lymphocyte and monocyte responses by 
examining cell subpopulations in the PB and SF, 
respectively, of patients with failed hip arthroplasties 
at revision surgery using a group with hip osteoarthritis 
requiring primary arthroplasty as controls. Differences 
were sought between sets of individuals undergoing 
revision of MoM hips compared with MoP hips to deter-
mine whether there were detectable distinctions in the 
immune responses between these groups.
No significant differences in the distribution of t-cell 
subtypes were found in the PB between the MoM, MoP 
and control groups. however, there were clear differ-
ences in the distribution of CD4+ t-cell subtypes in the SF 
compared with the PB of patients with failed MoM hips, 
there being a significant increase in the percentage of 
effector memory t-cells in the SF. Furthermore, there was 
a decrease in the percentages of naïve and central mem-
ory cells in SF compared with PB. In respect of cellular 
activation and antigen-presenting function, there was a 
significantly increased expression of co-stimulatory mol-
ecule ICoS on CD4+ cells in the PB of failed MoM and 
MoP hips compared with controls, as well as significantly 
increased expression of ICoS in the SF of MoM hips com-
pared with MoP hips. these findings support the concept 
that immune responses relating to the implant are pre-
sent where there is joint arthroplasty failure of MoP and 
MoM hips for aseptic loosening and ARMD.
Memory phenotypes of CD4+ T-cells in blood and synovial 
fluid. the demonstrated differences in CD4+ t-cell sub-
types present in the SF compared with PB in failed MoM 
hips may be important in understanding the pathogen-
esis of ARMD. the SF contained significantly increased 
CD4+ tEM cells compared with PB, and cells of this type 
typically show rapid entry into sites of inflammation with 
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Fig. 1
Graphs showing naïve and memory CD4+ t-cell subpopulations in two groups of revised hip arthroplasty patients and a control group with osteoarthritis: 
(a) Mononuclear cells gated for CD3+ and CD4+ were divided into naïve and memory sub-populations using CCR7 and CD45RA markers, (b) Pooled data for 
subpopulations of CD4+ t-cells in peripheral blood of the control group with osteoarthritis (oA) (n = 8). horizontal lines indicate medians, (c) Pooled data for 
blood CD4+ t-cell subpopulations in patients with metal-on-polyethylene (M-P) hips (n = 9). horizontal lines indicate medians,(d) Naïve and memory CD4+ 
t-cell populations in peripheral blood (n = 14) and synovial fluid (n = 10) of patients with metal-on-metal (M-M) hips (D). horizontal lines indicate medians. 
(tCM =central memory t-cell; tEM=effector memory t-cell; tN=naïve t-cell; tEMRA=terminally differentiated effector memory cell).
the secretion of large amounts of cytokines.15,16 While a 
previous report observed activated memory t-cells in the 
periprosthetic tissues of MoP hips,22 there were insufficient 
SF samples available from MoP hips to perform this analy-
sis in the present study. As substantial amounts of metal 
wear debris can be generated locally from MoM hips with 
poor implant design and/or suboptimal component posi-
tioning,23 it is hypothesised that this debris causes active 
engagement of the CD4+ tEM cells locally. this recruit-
ment may drive local immunological and inflammatory 
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Fig. 2
Graphs showing the expression of inducible co-stimulator (ICoS) on CD4+ t cells: (a) Expression of CD28 plotted against ICoS on CD3+ CD4+ t-cells. b) Pooled 
data of frequency of CD4+ CD28+ t-cells expressing ICoS in the peripheral blood of a control group with osteoarthritis (oA) (n = 8), MoM hips (n = 14) and 
MoP hips (n = 9). horizontal lines indicate medians. c) Median fluorescence intensity (MFI) of ICoS in the peripheral blood of a control group with osteoarthritis 
(oA) (n = 8), MoM hips (n = 14) and MoP hips (n = 9). horizontal lines indicate medians. d) the frequency of CD4+CD28+ICoS+ t-cells in the synovial fluid of 
patients with MoM (n = 11) and MoP hips (n = 6). horizontal lines indicate medians. e) MFI of ICoS on CD4+CD28+ t-cells in the synovial fluid of patients with 
MoM (n = 11) and MoP hips (n = 6). horizontal lines indicate medians.
responses which manifest clinically as bone and soft-tis-
sue destruction requiring early implant revision.23,24
Relationship between peripheral blood changes and local 
adverse tissue reactions. one study demonstrated that 
MoM hip patients with ARMD lesions had a significant 
increase in activated t-cells in PB compared with those 
without such lesions.20 By contrast, a recent report shows 
patients with MoM hips revised for pseudotumour have 
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lower levels of tM (memory t-cells) of both th (helper) 
and tC (cytotoxic) type in PB compared with failed MoM 
hips not having pseudotumours or those with well-func-
tioning MoM hips.21 this is in line with previous studies 
showing lower PB levels of t-lymphocyte subpopula-
tions in patients with MoM hips failing for ARMD.19,25-27 
Sequestration of t-cells at the local site of an immune 
reaction, namely the pseudotumour, has been suggested 
as one explanation.14,21 Alternatively, there may be acti-
vation of an homeostatic mechanism in the presence of 
active antigen presentation, involving a regulator of t-cell 
activation (cytotoxic t-lymphocyte antigen 4; CtlA-4) 
which is an alternative counterligand to CD28 and causes 
inhibition of t-cell activation.28,29 there is good evidence 
for active antigen presentation in the cellular reaction to 
wear debris in the local tissues and PB provided in various 
studies,11-14,30,31 as well as from in vitro cell culture experi-
ments.32,33 the correlation between elevated blood metal 
ions, particularly cobalt, and decreased t-cells has also 
been suggested as indicating a direct toxic and depres-
sive effect on these cells.19,27 Paradoxically, increased 
t-cells have been found in those with well-functioning 
MoM hips in both studies and this was correlated with 
elevated blood metal ion levels.17,18,20 the present study 
of MoM hip patients requiring revision surgery is in line 
with those showing no significant increase in t-cells, and 
it may be that the difference is simply the progression 
from normal functioning asymptomatic cases to those 
with failure.
Synovial fluid as a reflection of local adverse tissue reac-
tions. Examination of SF would seem to provide a likely 
means of assessing local rather than systemic effects, but 
it is noteworthy that there are no investigations in the lit-
erature in which the cellular changes in SF are reported. 
the present findings in which SF has also been investi-
gated support the notion that examination of PB may 
have limited value for assessing immune responses in 
relation to joint arthroplasties given that: (a) the profile 
of lymphocytic phenotypes present in the SF was not 
reflected systemically in the PB of MoM hip patients, 
(b) there were no differences between lymphocyte sub-
types in the PB between failed hips and controls, (c) apart 
from ICoS, there were no differences in the expression 
of co-stimulatory molecules in the PB between groups, 
and (d) there were no differences in the CD4+ th-cell 
subpopulations between groups as assessed by cytokine 
or transcription factor expression. this may explain why 
previous studies attempting to detect immune responses 
in relation to artificial joint arthroplasties using PB have 
been inconclusive.6
Expression of co-stimulatory molecules as evidence of anti-
gen presentation. In the only previous study of the co-
stimulatory molecules produced by PB monocytes, the 
expression of CD86 and hlA-DR, but not CD80 or CD40, 
was significantly higher in patients with MoM hips com-
pared with MoP hips, or in those who previously had a 
MoM joint revised to MoP.14 Paradoxically, CD28 expres-
sion by t-cells in the same samples showed higher lev-
els in the MoP cases and those with MoM hips revised 
to MoP, though there were CD28-expressing cells also 
present in the MoM samples.
In the present study, the co-stimulatory molecule 
ICoS, which is functionally related to CD28 and impor-
tant in t-cell activation and antigen presentation,34 was 
demonstrated to have significantly increased expression 
on the surface of CD4+CD28+ t-cells in the PB of patients 
with failed MoM and MoP hips compared with patients 
with osteoarthritis. this suggests that the local activation 
of t-cells in relation to artificial joint arthroplasties has the 
potential to generate immune responses.
the presence of ICoS was confirmed in the SF of 
patients with both failed MoM and MoP hips. this sub-
stantiates the activation of t-cells locally in relation to 
both types of implant. however, there was a significantly 
increased expression of ICoS in the SF of MoM hips com-
pared with MoP hips. Activated t-cells may play an 
important role in the aggravated immune responses gen-
erated against MoM implants seen in some studies.7,35,36 
Although immune responses may contribute to failure of 
both MoM and MoP hips, the increased expression of 
ICoS and propensity for antigen presentation in MoM 
hips may explain the clinical differences seen in the 
modes of failure between devices. ARMD can occur early 
after MoM bearing implantation and may be aggres-
sive,37,38 whereas failure of MoP joints with aseptic loos-
ening occurs more slowly over a number of years and is 
clinically less dramatic.39,40 Given that ARMD has recently 
been observed in patients with non-MoM bearing sur-
faces, namely those with modular junctions and dual-
taper designs,41,42 it would be interesting to perform 
similar SF analyses to those of the present study in 
patients with these devices.
the presence of B-cells and a follicular lymphoid 
response with t-cell and B-cell interactivity has not been 
noted in MoP joints.1,3,5,43-46 however, recent findings for 
MoM joints have shown B-cells present in some MoM 
hips revised for ARMD, and these cases may represent a 
distinct subset of patients with features of tertiary lym-
phoid organs in the periprosthetic tissues.7
Analysis of CD4 and T-cell subpopulations and cytokine 
expression. Evidence has been presented elsewhere that 
the response at the bone-implant interface for MoP joints 
is th1 cell-related, with activation of macrophages and 
t-cytotoxic/suppressor cells in a cell-mediated immune 
reaction with cytokine production and antigen presen-
tation.1,2,4 that different CD4+ t-cell subsets (th1, th2, 
th17 and t regulator) were present in the PB of MoM cases 
was evident in the current study, though significant dif-
ferences from MoP or controls were not found. Detailed 
examination of peri-implant tissues with respect to the 
markers used here has not been performed for MoM 
joints. Analysis of CD4+ t-cell subpopulations by means 
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of cell culture studies and cytokine expression on stim-
ulation of isolated cells is a relatively complex process 
in which reproducibility between laboratories may be 
difficult to achieve.
Future studies of cellular reactions to implanted joint 
arthroplasty devices. Although there is a large body of 
evidence with respect to the tissue changes around MoP 
joints which should be reflected in the SF, parallel studies 
of this fluid and peri-prosthetic tissues have not been per-
formed. that active antigen presentation occurs as part 
of the inflammatory response near the implant in MoP 
cases was proposed for the first time by Al-Saffar et al,12 
with subsequent confirmation of the expression of co-
stimulatory molecules CD80 and CD86 on macrophages 
and MNGCs, and CD28 on the related t-lymphocytes at 
the implant interface.11,30 the presence of CD40 on APCs 
and its counter-ligand, CD40l, on bone-implant interface 
lymphocytes has also been shown,13 while ICAM-1 and 
lFA-1 are present on interface macrophages and t-cells.31 
various functional studies in cell culture have revealed the 
expression of these co-stimulatory molecules in the con-
text of particle phagocytosis.11,32,33 the production of the 
NFκB family of molecules (RelA, RelB, c-rel, p50, p52) by 
both a monocytic cell line and normal PB monocytes on 
phagocytosis of metal particles has been demonstrated 
in cell culture experiments as well as in tissue samples 
of MoP implant interface using immunohistochemistry, 
quantitative Rt-PCR and FACS analysis.32,33 the pres-
ence of Rel B in interface inflammatory tissue and by cells 
phagocytosing wear debris in vitro is of some importance 
since this molecule is expressed by APCs only during 
their activation.33 there is no information available with 
respect to MoM joints having ARMD either for the expres-
sion of any of these markers or that of over 20 cytokines 
found in aseptic loosening of MoP joints1 so that there is 
a large scope for future investigation and clarification of 
the immunopathological processes occurring.
Examination of large numbers of cases (preferably in 
the thousands) might reveal differences, but this is clearly 
not feasible from single centres. Future subtleties may only 
be revealed by meta-analytical methods, and these analy-
ses in turn may be difficult to achieve where there is lack of 
conformity between laboratories, and even lack of consist-
ency in the definition of the pathological entities being 
studied (pseudotumour, ARMD, and aseptic lymphocyte-
dominated vasculitis-associated lesion (AlvAl)). It is 
recommended that future studies use both SF and peri-
prosthetic tissue samples to investigate the immune 
responses occurring in relation to the implants, and that 
more attention be paid to the definitions of the terms used.
there are limitations to this study. As expected, there 
were differences in the baseline characteristics of the 
cohort, including age, gender, and time to revision 
(table I). this is related to the inherent selection bias for 
the different types of arthroplasty, as well as obvious dif-
ferences in the mechanism of failure.37-40 Although it is 
recognised that such differences could affect the analysis 
performed, it is unlikely that these confounders can be 
overcome in future studies. It is acknowledged that the 
number of SF samples obtained was small, especially in 
MoP patients, therefore our conclusions must be inter-
preted with this in mind. however, this practical issue 
of obtaining insufficient samples for analysis would also 
be encountered in subsequent studies. Although blood 
metal ion and histopathology results have been pre-
sented, explant analysis was not performed which may 
have provided more details regarding the ARMD failures. 
Finally, it is recognised that no patients with well-func-
tioning hip arthroplasties were included in this analysis. 
this was because we were investigating mechanisms 
relating to implant failure, hence revised patients were 
recruited in preference. Although we therefore do not 
have baseline findings from samples in patients with 
well-functioning implants, it must be remembered that 
SF sampling in such patients is likely to raise significant 
ethical issues given the risk of inadvertently introducing 
infection. We do, however, have a baseline group of 
patients with primary hip osteoarthritis.
In conclusion, increased expression of the co-stimula-
tory molecule ICoS on the surface of CD4+CD28+ t-cells 
was observed in the PB and SF of patients with failed hip 
arthroplasties compared with patients with hip osteoar-
thritis. this suggests that immune responses with antigen 
presentation play an important role in the failure of both 
MoM and MoP hip arthroplasties. the increased expres-
sion of ICoS in the SF of MoM compared with MoP hips 
may explain the different modes of failure (ARMD versus 
aseptic loosening) observed with these two bearing 
surfaces. Differences in lymphocyte profiles in MoM hip 
patients in the SF compared with PB, and the lack of 
expression of other co-stimulatory molecules or cytokines 
in the blood suggest that PB examination has limited 
potential to detect immune responses occurring in rela-
tion to artificial joint arthroplasties. It is therefore recom-
mended that future studies use SF samples to investigate 
the immune responses which occur in relation to artificial 
joint arthroplasties, and that this should be performed in 
parallel with studies of peri-prosthetic tissue.
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